Interventional Therapies in Pulmonary Hypertension

Area of Science:

• Cardiology
• Pulmonary Medicine
• Interventional Cardiology

Background:

• Pulmonary hypertension (PH), particularly pulmonary arterial hypertension (PAH), is a fatal condition often leading to right heart failure (RHF).
• Current drug therapies primarily target pulmonary vascular resistance, but RHF management requires additional strategies.
• Unloading the right ventricle and enhancing systemic output are crucial for improving outcomes in RHF due to severe PH.

Purpose of the Study:

• To review the physiological basis, experimental evidence, and clinical benefits of interventional therapies for RHF in severe PH.
• To discuss the role of atrial septostomy, Potts anastomosis, and pulmonary artery denervation in unloading the right heart.
• To evaluate percutaneous balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Main Methods:

• Review of existing literature on interventional procedures for PH and RHF.
• Discussion of hemodynamic principles and physiological mechanisms.
• Analysis of clinical outcomes and experimental data.

Main Results:

• Interventional procedures aim to reduce right ventricular afterload and improve cardiac output.
• Atrial septostomy, Potts anastomosis, and pulmonary artery denervation can decompress the right heart.
• Percutaneous balloon pulmonary angioplasty is a viable option for inoperable CTEPH.

Conclusions:

• Interventional therapies offer promising adjunctive strategies for managing RHF in severe PH.
• These procedures provide alternative or complementary approaches to medical management.
• Further research is needed to fully elucidate the long-term benefits and optimal use of these interventions.